Downgrade Alert for BioCryst Pharmaceuticals (BCRX)

BioCryst Pharmaceuticals (NASDAQ:BCRX) was downgraded from Overweight to Neutral at Piper Jaffray today. The stock closed yesterday at $1.78 on volume of 9.3 million shares, above average daily volume...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.